How shorted was XERIS PHARMACEUTICALS INC? XERS
- vs previous report
- +0.24
- 5 reports (~10 weeks)
- +0.46
- days to cover
- 1.00
Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.
Days to cover
FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.
Short interest around results
For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.
| Results filed | Settlement before | Settlement after | Change |
|---|---|---|---|
| 5 Aug 2021 | 8.11% 30 Jul 2021 | 6.70% 13 Aug 2021 | −1.41 |
| 13 May 2021 | 20.12% 30 Apr 2021 | 23.01% 14 May 2021 | +2.89 |
| 9 Mar 2021 | 17.37% 26 Feb 2021 | 21.68% 15 Mar 2021 | +4.31 |
| 9 Nov 2020 | 31.33% 30 Oct 2020 | 30.23% 13 Nov 2020 | −1.10 |
| 10 Aug 2020 | 28.70% 31 Jul 2020 | 32.90% 14 Aug 2020 | +4.20 |
| 7 May 2020 | 5.65% 30 Apr 2020 | 6.23% 15 May 2020 | +0.58 |
| 11 Mar 2020 | 5.61% 28 Feb 2020 | 5.86% 13 Mar 2020 | +0.25 |
| 11 Feb 2020 | 7.90% 31 Jan 2020 | 4.71% 14 Feb 2020 | −3.19 |
Fails to deliver
The SEC's fails-to-deliver figure for XERS: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.
- Last balance on file
- 21
- 8 Sep 2026
- Highest in window
- 50,000
- 14 Jul 2026
- Days with a balance
- 29
- Window
- 16 Sep 2025 to 14 Sep 2026
Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 50K shares.
Embed this chart
Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview
Cite this page
Sector: Healthcare · By year: 2019 · 2020 · 2021
History
| Settlement date | Short % | Change |
|---|---|---|
| 31 Dec 2021 | 5.54% | +0.24 |
| 15 Dec 2021 | 5.30% | +0.73 |
| 30 Nov 2021 | 4.57% | −2.05 |
| 15 Nov 2021 | 6.62% | +0.84 |
| 29 Oct 2021 | 5.78% | +0.70 |
| 15 Oct 2021 | 5.08% | −1.05 |
| 30 Sep 2021 | 6.13% | −0.33 |
| 15 Sep 2021 | 6.46% | −0.90 |
| 31 Aug 2021 | 7.36% | +0.66 |
| 13 Aug 2021 | 6.70% | −1.41 |
| 30 Jul 2021 | 8.11% | −12.09 |
| 30 Jun 2021 | 20.20% | −3.26 |
| 15 Jun 2021 | 23.46% | +0.42 |
| 28 May 2021 | 23.04% | +0.03 |
| 14 May 2021 | 23.01% | +2.89 |
| 30 Apr 2021 | 20.12% | −7.56 |
| 15 Apr 2021 | 27.68% | −0.31 |
| 31 Mar 2021 | 27.99% | +6.31 |
| 15 Mar 2021 | 21.68% | +4.31 |
| 26 Feb 2021 | 17.37% | +5.35 |
| 12 Feb 2021 | 12.02% | +2.17 |
| 29 Jan 2021 | 9.85% | −1.18 |
| 15 Jan 2021 | 11.03% | +0.66 |
| 31 Dec 2020 | 10.37% | −0.40 |
| 15 Dec 2020 | 10.77% | −3.20 |
| 30 Nov 2020 | 13.97% | −16.26 |
| 13 Nov 2020 | 30.23% | −1.10 |
| 30 Oct 2020 | 31.33% | −6.87 |
| 15 Oct 2020 | 38.20% | +0.33 |
| 30 Sep 2020 | 37.87% | +3.28 |
| 15 Sep 2020 | 34.59% | −1.32 |
| 31 Aug 2020 | 35.91% | +3.01 |
| 14 Aug 2020 | 32.90% | +4.20 |
| 31 Jul 2020 | 28.70% | +25.00 |
| 15 Jun 2020 | 3.70% | −0.02 |
| 29 May 2020 | 3.72% | −2.51 |
| 15 May 2020 | 6.23% | +0.58 |
| 30 Apr 2020 | 5.65% | −1.09 |
| 15 Apr 2020 | 6.74% | +0.35 |
| 31 Mar 2020 | 6.39% | +0.53 |
| 13 Mar 2020 | 5.86% | +0.25 |
| 28 Feb 2020 | 5.61% | +0.90 |
| 14 Feb 2020 | 4.71% | −3.19 |
| 31 Jan 2020 | 7.90% | −0.19 |
| 15 Jan 2020 | 8.09% | +0.30 |
| 31 Dec 2019 | 7.79% | −0.59 |
| 13 Dec 2019 | 8.38% | +0.23 |
| 29 Nov 2019 | 8.15% | −0.20 |
| 15 Nov 2019 | 8.35% | −0.10 |
| 31 Oct 2019 | 8.45% | +0.24 |
| 15 Oct 2019 | 8.21% | – |
Newest first. Scroll inside the table for earlier dates, back to 15 Oct 2019.
Frequently asked questions
- How shorted was XERIS PHARMACEUTICALS INC?
- XERIS PHARMACEUTICALS INC left the US market in 2021. Its final reported figure was 5.54% of shares outstanding for settlement date 31 Dec 2021, per FINRA's consolidated short interest report; this page preserves its full history.
- What does this number include?
- FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
- Why does it only update twice a month?
- US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
- Is this XERS's short float?
- No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
- What is XERS's days to cover?
- 1.00 days for settlement date 31 Dec 2021: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
- Which funds are short?
- US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.